MicroVention Rebrands to Terumo Neuro

MicroVention, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation has officially rebranded to Terumo Neuro, effective immediately. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to creating and commercializing groundbreaking innovations in neurovascular care.
 
As Terumo Neuro, the company will continue its close collaboration with leading physicians worldwide, translating clinical insights into technologies that enhance patient outcomes. 
 
Carsten Schroeder, President and CEO of Terumo Neuro, commented:  “This transformation reflects our growth as a company and Terumo’s confidence in our future. For eighteen years, we have maintained independent branding as MicroVention, and now, as Terumo Neuro, we’re combining the best of MicroVention with the full strength and support of the Terumo family. Our culture, speed of innovation, focus on game-changing technologies, and close collaboration with physicians will remain unchanged.”
 
MicroVention was founded in 1997 and acquired by Terumo Corporation in 2006. Since then, it has been forefront of developing technologies that support neurovascular surgeons in preserving and restoring brain health. As Terumo Neuro, the company is poised to continue its legacy of innovation with an enhanced focus on driving impactful growth and leveraging Terumo’s global resources and reputation.
 
“What will evolve is a deeper partnership with Terumo, a new visual brand, and a more defined brand identity under our new name and slogan, ‘Terumo Neuro:  Game-changing Impact.’ Our strategy is expanding beyond our core focus on hemorrhagic and ischemic stroke and access solutions to encompass the neurovascular patient care continuum,” Schroeder added. 
 
Schroeder emphasized that the company’s DNA remains rooted in innovation for ischemic stroke, hemorrhagic stroke, and access while expanding into broader areas of neurovascular care.